512 related articles for article (PubMed ID: 8495410)
21. Impaired expression of microsomal cytochrome P450 2C11 in choline-deficient rat liver during the development of cirrhosis.
Murray M; Cantrill E; Mehta I; Farrell GC
J Pharmacol Exp Ther; 1992 Apr; 261(1):373-80. PubMed ID: 1560381
[TBL] [Abstract][Full Text] [Related]
22. Suppression of rat hepatic microsomal cytochromes P450 by cyclophosphamide is correlated with plasma thyroid hormone levels and displays differential strain sensitivity.
Kraner JC; Morgan ET; Poet TS; Born SL; Burnett VL; Halpert JR
J Pharmacol Exp Ther; 1996 Jan; 276(1):258-64. PubMed ID: 8558440
[TBL] [Abstract][Full Text] [Related]
23. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
Hales BF
Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
[TBL] [Abstract][Full Text] [Related]
24. Regulation of hepatic cytochrome P450 2C11 by transforming growth factor-beta, hepatocyte growth factor, and interleukin-11.
Iber H; Morgan ET
Drug Metab Dispos; 1998 Oct; 26(10):1042-4. PubMed ID: 9763412
[TBL] [Abstract][Full Text] [Related]
25. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
Murray M
Mol Pharmacol; 1992 Nov; 42(5):931-8. PubMed ID: 1435757
[TBL] [Abstract][Full Text] [Related]
26. Modulation of rat cytochrome P-450 by an investigational HIV protease inhibitor.
Nishime JA; Wang RW; Lin JH; Chiba M
Drug Metab Dispos; 1999 Sep; 27(9):972-6. PubMed ID: 10460793
[TBL] [Abstract][Full Text] [Related]
27. Regulation of hepatic cytochrome P450 2C11 by glucocorticoids.
Iber H; Chen Q; Sewer M; Morgan ET
Arch Biochem Biophys; 1997 Sep; 345(2):305-10. PubMed ID: 9308903
[TBL] [Abstract][Full Text] [Related]
28. Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor alpha.
Nadin L; Butler AM; Farrell GC; Murray M
Gastroenterology; 1995 Jul; 109(1):198-205. PubMed ID: 7797018
[TBL] [Abstract][Full Text] [Related]
29. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats.
Parkin DR; Lu Y; Bliss RL; Malejka-Giganti D
Food Chem Toxicol; 2008 Jul; 46(7):2451-8. PubMed ID: 18486294
[TBL] [Abstract][Full Text] [Related]
31. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
Spielmann H; Jacob-Müller U
Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
Hales BF
Cancer Res; 1982 Aug; 42(8):3016-21. PubMed ID: 7046914
[No Abstract] [Full Text] [Related]
33. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
Kawabata TT; White KL
Cancer Res; 1988 Jan; 48(1):41-5. PubMed ID: 3257162
[TBL] [Abstract][Full Text] [Related]
34. Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats.
Chen J; Robertson G; Field J; Liddle C; Farrell GC
Hepatology; 1998 Sep; 28(3):624-30. PubMed ID: 9731550
[TBL] [Abstract][Full Text] [Related]
35. Reproductive toxicity and growth effects in rats exposed to lead at different periods during development.
Ronis MJ; Badger TM; Shema SJ; Roberson PK; Shaikh F
Toxicol Appl Pharmacol; 1996 Feb; 136(2):361-71. PubMed ID: 8619245
[TBL] [Abstract][Full Text] [Related]
36. Induction of cytochrome P450 1A1 and 1A2 by hyperoxia.
Okamoto T; Mitsuhashi M; Fujita I; Sindhu RK; Kikkawa Y
Biochem Biophys Res Commun; 1993 Dec; 197(2):878-85. PubMed ID: 8267628
[TBL] [Abstract][Full Text] [Related]
37. Green tea extract increases cyclophosphamide-induced teratogenesis by modulating the expression of cytochrome P-450 mRNA.
Park D; Jeon JH; Shin S; Joo SS; Kang DH; Moon SH; Jang MJ; Cho YM; Kim JW; Ji HJ; Ahn B; Oh KW; Kim YB
Reprod Toxicol; 2009 Jan; 27(1):79-84. PubMed ID: 19103281
[TBL] [Abstract][Full Text] [Related]
38. Selective suppression of rat hepatic microsomal activity during chronic cyclosporine nephrotoxicity.
Brunner LJ; Bennett WM; Koop DR
J Pharmacol Exp Ther; 1996 Jun; 277(3):1710-8. PubMed ID: 8667242
[TBL] [Abstract][Full Text] [Related]
39. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
Panesar SK; Bandiera SM; Abbott FS
Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
[TBL] [Abstract][Full Text] [Related]
40. Lack of effect of methotrexate on the expression of constitutive hepatic cytochromes P450 in the male rat.
Cheung RL; Lee C; Jones EJ; Riddick DS
Xenobiotica; 1996 May; 26(5):503-14. PubMed ID: 8736062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
